Epilepsy and Seizure News
Seizure action plans: Management and educational tools in epilepsy care -
Historically, seizure action plans have focused on certain high-risk groups—such as people with drug-resistant epilepsy and people with a history of status epilepticus or seizure clusters. Neurology ...
Using Seizure-Risk Forecasts to ID Best Time for Epilepsy Monitoring -
NASHVILLE, Tennessee ― Scheduling video-electroencephalography (vEEG) monitoring on the basis of personalized seizure risk forecasts may improve diagnostic accuracy, emerging research suggests. In a ...
Focal treatment-resistant epilepsy symptoms improved with antiseizure medication -
Please provide your email address to receive an email when new articles are posted on . Monthly seizure frequency percentage reduction was 68.73% for the entire study cohort. For those followed up in ...
Seizure or epilepsy? Understanding the critical difference could save lives -
A sudden episode of shaking, confusion, or loss of awareness can be frightening - but does it mean epilepsy? Understanding the difference between a seizure and epilepsy is crucial for timely treatment ...
Seizure Burden in Resistant Epilepsy May Ease With the Tincture of Time -
Nearly 70% of patients with focal treatment-resistant epilepsy (FTRE) experience fewer seizures over time, new results of a multicenter study showed. However, the improvements occurred independent of ...
NEURELIS PRESENTS STUDIES ON SEIZURE CLUSTERS AT THE AMERICAN EPILEPSY SOCIETY ANNUAL MEETING -
SAN DIEGO, Dec. 6, 2024 /PRNewswire/ -- Neurelis, Inc., today announced details of its presentations at the American Epilepsy Society (AES) Annual Meeting to be held December 6-10 in Los Angeles. The ...
In people with epilepsy, sleeping after a seizure may trigger more seizures -
Add Yahoo as a preferred source to see more of our stories on Google. A new study suggests that the memory-forming stage of sleep could be key for understanding epileptic seizures. . | Credit: ...
Does Levetiracetam Improve Seizure Outcomes in Pediatric Epilepsy? -
Although levetiracetam was associated with improved seizure outcomes compared with placebo in pediatric epilepsy, it did not demonstrate superior efficacy when compared with established active ...
Neurofeedback News
What Is Neurofeedback Therapy? -
Neurofeedback is a noninvasive form of therapy that trains the brain to improve various neurological issues, including chronic pain, ADHD, anxiety, depression and PTSD. Using EEG to monitor real-time ...
Rewiring Your Brain: Neurofeedback Goes Mainstream -
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Will Strahl walked up to my door with a massive black briefcase in his ...
Neurofeedback Gains Popularity and Lab Attention -
You sit in a chair, facing a computer screen, while a clinician sticks electrodes to your scalp with a viscous goop that takes days to wash out of your hair. Wires from the sensors connect to a ...
Neurofeedback Therapists in San Antonio, TX -
I use neuroscience-informed individual psychotherapy, EMDR, Somatic Experiencing, IFS and Ego State Therapy, DBT, trauma-focused CBT, attachment-based therapy, motivational interviewing, ...
What Does a Neurofeedback Technician Do? -
Neurofeedback is about helping a client's brain learn to self-regulate by showing it its own EEG activity on a screen or through headphones. It is like going to the gym for your brain. It is not a ...
Medical News Today
PubMed
A decade later: a longitudinal retrospective cohort study of the clinical course of childhood-onset epilepsy in a multi-ethnic tertiary centre -
CONCLUSIONS: Childhood-onset epilepsy is associated with substantial long-term neurodevelopmental and psychosocial consequences. Our findings highlight the need for individualized, multidisciplinary management and clear, structured transition pathways from paediatric to adult neurology services. We outline several recommendations to enhance overall management as patients transition into adulthood.
Current role of cannabis in therapeutics: A critical perspective -
This article offers a critical overview of the therapeutic role of cannabis and cannabinoids following their recent regulation in Spain through Royal Decree 903/2025 for the use of standardized compounded formulations. In chronic pain, cannabis is not considered a high-potency analgesic, but rather a third-line option for refractory cases, especially neuropathic pain. Its benefit is modest and ...
Stem cell-based therapeutics in epilepsy: current advances and future prospects -
Epilepsy represents as one of the most prevalent and serious neurological disorders, with approximately one-third of patients resistant to conventional treatments. Current pharmacologic therapies primarily suppress seizures without targeting the underlying epileptogenesis, resulting in unchanged long-term prognosis. At the same time, epilepsy surgery remains underutilized due to the requirement...
Effects of maternal docosahexaenoic acid intake on febrile seizures and increased seizure susceptibility after febrile seizures: Study using mouse models and human samples -
The effects of docosahexaenoic acid (DHA) on seizures and epilepsy remain controversial and appear to depend on the specific context. In this study, we investigated the effects of maternal DHA intake on febrile seizures and post-febrile seizure susceptibility. Mice exposed to DHA during pregnancy showed considerably higher brain DHA and 17β-estradiol (E2) levels than controls, along with a mark...
Digital health literacy and quality of life in epilepsy: The mediating role of self-management -
CONCLUSIONS: Digital health literacy was associated with quality of life in epilepsy, with self-management accounting for a significant indirect association. These findings highlight the potential value of combining digital health literacy initiatives with structured self-management support.
Perampanel in real-world epilepsy setting: results from the PERSICILIA study -
In this multicentre, retrospective, real-world study, we evaluated 254 people with epilepsy initiating adjunctive perampanel in routine clinical practice. Treatment retention was high at 6 and 12 months (90.9% and 81.9%). In observed cases, ≥50% seizure reduction was achieved by 80.5% and 78.8%, while seizure freedom was reached by 28.1% and 25.5%, respectively. Conservative baseline-denominato...
Science Daily